The role of pregabalin in neuropathic pain management in cancer patients

Abstract

Despite the wide availability of analgesics for prescription in cancer pain, including both opioid and non-opioid medications, population studies have for many years demonstrated unadvisable pain management. International analyses indicate inadequate use of opioid and adjuvant drugs per capita. At the same time, patients complain about the accompanying pain, not treated effectively, especially in the course of cancer. One of the many causes of cancer pain that is difficult to treat is the co-occurrence of neuropathic pain. The article presents contemporary views on the treatment of neuropathic pain associated with cancer, including the site of application of gabapentinoids in the treatment scheme.